Abstract
Background Malignant gliomas (MG) comprise the most common types of primary central nervous system tumours.PurposeAn observational study to evaluate the efficacy and safety of bevacizumab plus irinotecan used off-label in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
